autoimmune disease news from FierceBiotech

There are two new spin-offs to announce today. First, Battelle Ventures has spun out regenerative medicine start-up NellOne Therapeutics from the U.S. Department of Energy's Oak Ridge National Read more...

Rumors are swirling that Pfizer is looking to take over the German biotech Read more...

The FDA has granted priority review to Talecris' drug Gamunex, meaning the FDA will review its application in six months rather than the standard 10. Gamunex is an IGIV therapy that contains Read more...

Frazier Healthcare Ventures and Domain Associates have joined forces to lead a $27 million Series B for Nuon Therapeutics, a San Mateo, CA-based developer working on new therapies for autoimmune and Read more...

> How might drugmakers navigate the rocky waters of generic competition, cautious regulators, safety scandals, globalization, and so on? Seek help with the itinerary from an expert, perhaps. At Read more...

Teva has whetted at least part of its appetite for fresh acquisitions with the announcement this morning that it is buying CoGenesys for $400 million in cash. The Israeli generic drug company says Read more...

Tolerx has scored a Big Pharma partner in its race to develop a monoclonal antibody (MAb) that may protect people from Read more...

Eli Lilly is putting down a $41 million payment to acquire exclusive rights to MacroGenics' diabetes drug teplizumab in a deal that could be worth more than a billion dollars in total. Read more...

Nuon Therapeutics Completes Licensing, Supply and Collaboration Agreement on Tranilast With Kissei Pharmaceutical Nuon Therapeutics, Inc., a clinical stage biotechnology company, today announced the

Read more...

Forbes takes a close look at Genentech's new venture in immunology. After a string of huge successes in oncology, its researchers will now be judged by their success in a new field. Scientist Andy Chan has been brought in from UC San Francisco to help search for more effective therapies for rheumatoid arthritis. He's looking to new advances in genomics to identify the …

Read more...